Literature DB >> 25732759

Treatment for diabetic foot ulcers complicated by major cardiac events.

Shih-Yuan Hung1, Yu-Yao Huang1, Lung-An Hsu2, Chun-Chi Chen2, Hui-Mei Yang1, Jui-Hung Sun1, Cheng-Wei Lin1, Chih-Ching Wang3.   

Abstract

OBJECTIVE: Diabetic foot ulcer (DFU) is a major complication in patients with diabetes mellitus and the leading cause of non-traumatic amputation in adults. Patients with DFU are usually fragile due to chronic diabetic comorbidities; therefore, tedious debridement and intervention procedures may not be well tolerated in patients with DFU. This study aimed to identify a casual relationship between in-hospital complications and treatment for limb-threatening DFUs.
METHODS: From 2009 to 2011, 1130 consecutive patients who were admitted to the Diabetic Foot Care Center in Chang Gung Medical Center were surveyed. Rates of in-hospital mortality or events that lead to transfer to the intensive care unit (ICU) for various severe complications were retrospectively analyzed.
RESULTS: Forty-seven patients (4.2%) experienced in-hospital complications (28 patients died). Major adverse cardiac events (MACE) (n=21, 44.7%) were the most common complications, followed by nosocomial infection (n=18, 38.3%). Previous myocardial infarction was a risk factor for MACE. The presentation of MACE was fulminant (eg, acute pulmonary edema, cardiogenic shock,cardiac arrest), and occurred within 10 days of admission or within 10 days following a major procedure in most cases. ST-T segment abnormality at rest was the most common presentation of electrocardiography for MACE.
CONCLUSION: MACE should be prevented during treatment for limb-threatening DFU in high-risk patients. Acute stress might have caused MACE during the first 10 days after admission or a major procedure.
Copyright © 2015 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  In-hospital complication; MACE; NSTEMI; complication à l'hôpital; diabetic foot ulcer; ulcère du pied diabétique; évènements indésirables cardiaques majeurs

Mesh:

Year:  2015        PMID: 25732759     DOI: 10.1016/j.jcjd.2014.11.002

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


  5 in total

1.  Associations of Estimated Glomerular Filtration Rate with All-Cause Mortality and Cardiovascular Mortality in Patients with Diabetic Foot Osteomyelitis.

Authors:  Jianhao Huang; Weiwei Li; Suosu Wei; Xing Zhou; Yuechou Nong; Jingxia Sun; Zhenwei Zhai; Wensheng Lu
Journal:  Int J Gen Med       Date:  2021-08-14

2.  Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene.

Authors:  Yu-Yao Huang; Cheng-Wei Lin; Hui-Mei Yang; Shih-Yuan Hung; I-Wen Chen
Journal:  J Foot Ankle Res       Date:  2018-01-04       Impact factor: 2.303

3.  Diabetic Foot Infection Presenting Systemic Inflammatory Response Syndrome: A Unique Disorder of Systemic Reaction from Infection of the Most Distal Body.

Authors:  Cheng-Wei Lin; Shih-Yuan Hung; Chung-Huei Huang; Jiun-Ting Yeh; Yu-Yao Huang
Journal:  J Clin Med       Date:  2019-09-25       Impact factor: 4.241

4.  The analysis for time of referral to a medical center among patients with diabetic foot infection.

Authors:  Cheng-Wei Lin; Hui-Mei Yang; Shih-Yuan Hung; I-Wen Chen; Yu-Yao Huang
Journal:  BMC Fam Pract       Date:  2021-01-09       Impact factor: 2.497

5.  Impact of wound microbiology on limb preservation in patients with diabetic foot infection.

Authors:  Shih-Yuan Hung; Cheng-Hsun Chiu; Chung-Huei Huang; Cheng-Wei Lin; Jiun-Ting Yeh; Hui-Mei Yang; Yu-Yao Huang
Journal:  J Diabetes Investig       Date:  2021-09-08       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.